Lv613
2346 积分 2023-02-27 加入
Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling
2天前
已完结
Drug firms’ secret data supercharge AI protein models
3天前
求助中
De novo development of small cyclic peptides that are orally bioavailable
3天前
已完结
Tutorial: guidance on the use of large language models for medical research
17天前
已完结
Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders
18天前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RAS G12D aspartic acid in tumors
21天前
已完结
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design
22天前
已完结
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
22天前
已完结
Improving pancreatic adenocarcinoma prognosis models through ligand receptor interactions and histopathological integration
23天前
已完结
Derisking AffinityOptimization for Macrocycles andCyclic Peptides: High-Precision Free Energy Simulations across FiveDiverse Targets
29天前
已关闭
皖公网安备34019202002308
